WebFeb 10, 2024 · Rivus Pharmaceuticals has reported positive data from a Phase IIa trial, in which its therapy HU6 demonstrated fat and weight reduction in obese subjects. The Phase IIa metabolic study is intended to support multiple Phase IIb trials in metabolic disease including type 2 diabetes, severe hypertriglyceridemia, and nonalcoholic steatohepatitis ... WebSep 23, 2024 · Executives On The Move: Changes At AN2 Therapeutics, Cabaletta Bio And More 13 Jan 2024. Scrip. Biogen Halves Aduhelm Price, Readies $500m In Cost Cuts 20 Dec 2024. Scrip. Finance Watch: Four New ... Rivus Raises $132m In Series B Cash To Fund Obesity Drug Trials Add a personalized message to your email. Cancel. Send. Please …
Francesco De Rubertis Medicxi
WebAbout. Rivus Pharmaceuticals, a leader in mitochondrial biology, is advancing a new class of medicines designed to address a primary driver of cardio-metabolic diseases: obesity. Harnessing the natural process of mitochondrial uncoupling, Rivus’ Controlled Metabolic Accelerators (CMAs) provide a new, measured approach to reducing fat ... WebRivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, today announced the completion of a $132 million … chris soldevilla wikipedia
Rivus Pharmaceuticals Careers, Perks + Culture Built In
WebSep 22, 2024 · Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, today announced the completion of a $132 million Series B financing led by RA ... WebSep 22, 2024 · About Rivus Pharmaceuticals Rivus Pharmaceuticals, Inc., a leader in mitochondrial biology, is dedicated to improving cardio-metabolic health by advancing a new class of medicines, Controlled ... WebRivus Pharmaceuticals Overview. Founded Year 2024. Location Charlottesville, United States. Company Stage Series A. Total Funding $35M. Last Funding Round $35M, Series A, Jun 20, 2024. Similar Cos. Sarepta, Tenaya Therapeutics, Esperion Therapeutics, Portola Pharma, Aegerion & 298 others Disclaimer: Total Funding = Total Disclosed Equity … geological bulletin of china缩写